Neurocrine

Trade Neurocrine Biosciences, Inc. - NBIX stock price

1m
5m
15m
30m
1H
4H
1D
1W
History
Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's lead products include INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2), which is used for the treatment of movement disorders; elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that is in Phase III clinical trial for use in women's health; and opicapone, a catechol-O-methyltransferase inhibitor, which is in Phase III clinical trial that is used for in adjunct therapy and preparations of levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson's disease. It is also developing NBI-74788, which is in Phase II clinical trial that is used for the treatment of congenital adrenal hyperplasia. In addition, the company's research programs comprise VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, dystonia, and other indications. It has collaborations and agreements with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women's and men's health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize INGREZZA for movement disorders; and BIAL Portela & Ca, S.A. to develop and commercialize opicapone for the treatment of human diseases and conditions, including Parkinson's disease. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Articles
Humanity Protocol secures investment from Polygon, Animoca founders
Dogwifhat’s WIF jumps 7% following listing on Robinhood Crypto
Binance expands VIP program to attract traditional asset holders
Telegram limits its TON holdings at 10% after channel owner rewards rollout
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

NBIX price history

Date Close Change Chg% Open Min. Max.
2022-09-30 105.48 -0.80 -0.75 106.28 105.36 108.18
2022-09-30 106.96 -0.75 -0.70 107.71 105.06 107.73
2022-09-30 107.7 2.37 2.25 105.33 104.63 108.37
2022-09-30 105.96 -0.74 -0.69 106.7 104.5 107.12
2022-09-30 106.77 3.82 3.71 102.95 102.95 106.9
2022-09-30 104.13 1.54 1.50 102.59 100.25 104.28
2022-09-30 102.59 -3.13 -2.96 105.72 102.53 105.78
2022-09-30 106.51 0.28 0.26 106.23 103.33 106.8
2022-09-30 106.31 -0.57 -0.53 106.88 105.87 107.37
2022-09-30 106.5 1.47 1.40 105.03 104.46 108.05
2022-09-30 105.38 2.47 2.40 102.91 102.02 105.82
2022-09-30 102.87 -0.01 -0.01 102.88 101.54 103.47
2022-09-30 102.81 -2.49 -2.36 105.3 102.59 105.87
2022-09-30 105.46 2.35 2.28 103.11 101.79 105.55
2022-09-30 104.48 1.36 1.32 103.12 103.12 105.55
2022-09-30 103.12 -0.93 -0.89 104.05 102.1 104.57
2022-09-30 105.18 1.33 1.28 103.85 103.85 106.31
2022-09-30 104.74 3.03 2.98 101.71 101.71 105.63
2022-09-30 104.17 -1.89 -1.78 106.06 103.6 106.99
2022-09-30 106.32 1.79 1.71 104.53 104.52 107.71
Go help.dzengi.com